SCHEMBL2960456

SCHEMBL2960456

O=S(=O)(c1cccc(Cl)c1)N1CCN(c2ccccc2)CC1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.68
▸ KMT2A Q03164 5/20 0.68
▸ ALDH1A1 P00352 4/20 0.68
▸ HTT P42858 2/20 0.65
▸ LMNA P02545 4/20 0.63
▸ THRB P10828 1/20 0.63
▸ PKM P14618 2/20 0.63
▸ GBA1 P04062 1/20 0.59
▸ HPGD P15428 1/20 0.58
▸ MAPT P10636 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ HDAC3 O15379 1/20 0.58
▸ HDAC4 P56524 1/20 0.58
▸ HDAC1 Q13547 1/20 0.58
▸ HDAC7 Q8WUI4 1/20 0.58
▸ HDAC2 Q92769 1/20 0.58
▸ HDAC10 Q969S8 1/20 0.58
▸ HDAC11 Q96DB2 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20887055 0.93 ALDH1A1 (0.64) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL10726996 0.87 ALDH1A1 (0.86) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL5245856 0.87 MEN1 (0.62) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL616835 0.84 ALDH1A1 (0.78) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL5249712 0.84 LMNA (0.68) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL2963235 0.83 ALDH1A1 (0.72) MEN1KMT2AALDH1A1LMNATHRB
SCHEMBL2956564 0.82 HTT (0.65) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL12089437 0.82 HSD11B1 (0.59) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL15101885 0.82 CHRM1 (0.82) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL5772658 0.81 PTPN11 (0.62) MEN1KMT2AALDH1A1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759339-B2 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. (US) 2010-07-20 — — US claimed
EP-1866298-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS Takeda San Diego, Inc. (US) 2007-12-19 — — EP claimed
WO-2006105127-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2006-10-05 — — WO claimed
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. 2006-10-05 — — US claimed
US-7759339-B2 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. (US) 2010-07-20 — — US disclosed
US-7759339-B2 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. (US) 2010-07-20 — — US disclosed
US-7759339-B2 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. (US) 2010-07-20 — — US disclosed
EP-1866298-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS Takeda San Diego, Inc. (US) 2007-12-19 — — EP disclosed
WO-2006105127-A2 HYDROXYSTEROID DEHYDROGENASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2006-10-05 — — WO disclosed
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors TAKEDA SAN DIEGO, INC. 2006-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223829-A1 Hydroxysteroid dehydrogenase inhibitors HSD17B1, HSD17B3, HSD17B2 MEN1 2689/4885KMT2A 3335/4885ALDH1A1 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback